Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years

Elmir Omerovic*, Stefan James, Truls Råmundal, Ole Fröbert, Rikard Linder, Mikael Danielewicz, Mehmet Hamid, Christos Pagonis, Loghman Henareh, Henrik Wagner, Jason Stewart, Jens Jensen, Pontus Lindros, Lotta Robertsson, Helena Wikström, Anders Ulvenstam, Pallonji Bhiladval, Tim Tödt, Dan Ioanes, Thomas KellerthLeszek Zagozdzon, Matthias Götberg, Jonas Andersson, Oskar Angerås, Ollie Östlund, Claes Held, Sasha Koul, David Erlinge

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Fingeraftryk

Dyk ned i forskningsemnerne om 'Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology